Science Explorer Interactive view Map
Institution · Kiel · Germany

German Inflammatory Bowel Diseases Study Group

Research works
52
▼ 5% vs 2013–17
Citations
1.1k
22.1 per fractional work
Top-10% rate
22.5%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: German Inflammatory Bowel Diseases Study Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.30× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.20× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 3.47× its world share, 0 worksImmunology and Micro…Physics and Astronomy: 0.04× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.08× its world share, 0 worksHealth ProfessionsMedicine: 3.28× its world share, 4 worksMedicineArts and Humanities: 5.90× its world share, 1 worksArts and HumanitiesEconomics, Econometrics and Finance: 1.33× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.22× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Arts and Humanities, 5.9×. Every wedge is a field page.

Which keywords describe research at German Inflammatory Bowel Diseases Study Group?

By fractional works in all years, weighted toward what it does more of than the world: Rituximab, PET Imaging, Lymphoma, Classification, Molecular Profiling, Prognostic Factors, Targeted Therapy and Chemotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Rituximab16▲ 195×3 topics
  2. PET Imaging14▲ 122×2 topics
  3. Lymphoma13▲ 170×3 topics
  4. Classification12▲ 66×1 topic
  5. Molecular Profiling12▲ 201×1 topic
  6. Prognostic Factors6▲ 24×5 topics
  7. Targeted Therapy5▲ 47×5 topics
  8. Chemotherapy5▲ 13×12 topics
  9. Radiotherapy4▲ 19×8 topics
  10. Therapeutic Targets4▲ 30×4 topics
  11. Chronic Lymphocytic Leukemia4▲ 144×1 topic
  12. Genomic Aberrations4▲ 144×1 topic
  13. Treatment Guidelines4▲ 32×2 topics
  14. ALK Inhibitors3▲ 118×1 topic
  15. Clinical Trials3▲ 11×2 topics
  16. EGFR Mutations3▲ 118×1 topic
  17. Prognostic Scoring System3▲ 159×2 topics
  18. Methotrexate3▲ 365×1 topic
  19. Primary CNS Lymphoma3▲ 365×1 topic
  20. Cancer Incidence2▲ 26×2 topics
  21. Breast Cancer2▲ 12×5 topics
  22. Immunosuppression2▲ 28×2 topics
  23. Dosimetry2▲ 34×2 topics
  24. Epstein-Barr Virus2▲ 103×1 topic
  25. Kaposi's Sarcoma2▲ 103×1 topic
  26. Cancer Treatment2▲ 11×2 topics
  27. Metastatic Breast Cancer2▲ 44×2 topics
  28. Radioimmunotherapy1▲ 67×1 topic
  29. Radiopharmaceuticals1▲ 67×1 topic
  30. Corporate Governance1▲ 4.1×2 topics
  31. CDK4/6 Inhibitors1▲ 131×1 topic
  32. Palbociclib1▲ 131×1 topic
  33. Pediatric Oncology1▲ 39×2 topics
  34. Acute Lymphoblastic Leukemia1▲ 55×1 topic
  35. Adaptive Reuse1▲ 68×1 topic
  36. Childhood Cancer1▲ 55×1 topic
  37. Derivatives1▲ 32×1 topic
  38. Hedging1▲ 130×1 topic
  39. Intangible Heritage1▲ 68×1 topic
  40. Survival1▲ 15×3 topics

Which research topics does German Inflammatory Bowel Diseases Study Group publish most on?

By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Cultural Heritage Management and Preservation, Lung Cancer Treatments and Mutations and Cancer Genomics and Diagnostics.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  2. 2 Cultural Heritage Management and Preservation Archeology 1 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 0 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Healthcare Policy and Management Economics and Econometrics 0 works
  8. 8 Socioeconomic Development in MENA Sociology and Political Science 0 works
  9. 9 Patient Satisfaction in Healthcare General Health Professions 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.7%not open65.3%

World: 28% of research is openly available.

with international co-authors35.0%domestic only65.0%

World: 19% is written across borders.

How has German Inflammatory Bowel Diseases Study Group's research output changed?

Output in 2018–2022 was 5% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Kiel

All research institutions in Kiel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.